![Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hyd…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F363518-cyclopropaneacetic-acid-1-1r-1-3-1e-2-7-chloro-2-quinolinyl-ethenyl-phenyl-3-2-1-hydroxy-1-methylethyl-phenyl-propyl-thio-methyl-sodium-salt-1-1.webp&w=3840&q=75)
CAS 151767-02-1
:Ácido ciclopropanoacético, 1-[[[(1R)-1-[3-[(1E)-2-(7-cloro-2-quinolinil)etenil]fenil]-3-[2-(1-hidroxi-1-metiletil)fenil]propil]tio]metil]-, sal de sodio (1:1)
Descripción:
Ácido ciclopropanoacético, 1-[[[(1R)-1-[3-[(1E)-2-(7-cloro-2-quinolinil)etenil]fenil]-3-[2-(1-hidroxi-1-metiletil)fenil]propil]tio]metil]-, sal de sodio (1:1) es un compuesto orgánico complejo caracterizado por sus características estructurales únicas, incluyendo un anillo de ciclopropano y varios grupos funcionales que contribuyen a su reactividad química y actividad biológica. Como sal de sodio, es probable que exhiba una mayor solubilidad en agua en comparación con su forma ácida, lo que puede mejorar su biodisponibilidad en aplicaciones farmacéuticas. La presencia de un grupo quinolina sugiere propiedades farmacológicas potenciales, posiblemente incluyendo actividades antimicrobianas o anticancerígenas. El enlace tioéter del compuesto también puede influir en su estabilidad y reactividad. Su estructura intrincada indica que puede interactuar con objetivos biológicos de manera específica, lo que lo hace de interés en la química medicinal. En general, este compuesto ejemplifica la complejidad que a menudo se encuentra en moléculas similares a fármacos, combinando múltiples grupos funcionales que pueden conferir diversas propiedades químicas y biológicas.
Fórmula:C35H36ClNO3S·Na
InChI:InChI=1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/b15-10+;/t32-;/m1./s1
Clave InChI:InChIKey=ZMFQNQCXWQXCFO-HKHDRNBDSA-N
SMILES:C(S[C@H](CCC1=C(C(C)(C)O)C=CC=C1)C2=CC(/C=C/C3=NC4=C(C=C3)C=CC(Cl)=C4)=CC=C2)C5(CC(O)=O)CC5.[Na]
Sinónimos:- 1-[[[(R)-1-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid sodium salt
- 2-[1-[[1-[3-[2-[(7-Chloro-2-Quinolyl)]Vinyl]Phenyl]-3-[2-(1-Hydroxy-1-Methyl-Ethyl)Phenyl]-Propyl]Sulfanylmethyl]Cyclopropyl]Acetic Acid Sodium Salt
- 2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid sodium salt
- Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt
- Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
- Cyclopropaneacetic acid, 1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt, [R-(E)]-
- Kokast
- Methyl-[E]-(+)-1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)-ethenyl]phenyl]-3-[2-(1-hydroxyl-1-methylethyl)phenyl]propyl]mercapto]methyl]cyclopropane acetic acid sodium
- Mk-476
- Momazol
- Montair
- Montelukast Sodium Amorphous
- Montelukast monosodium salt
- Montikast
- Shantroz
- Singulair
- Sodium 2-[1-[[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetate
- Sodium montelukast
- sodium (1-{[(1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl)sulfanyl]methyl}cyclopropyl)acetate
- sodium {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetate
- sodium(R,E)-2-(1-(1-(3-(-(7-chloroqulnolln-2-yl)-3-(2-(2 hydroxypropan-2-yl)phenyl)propylthio)cyclopropyl)acetate
- Ver más sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 19 productos.
MONTELUKAST FOR PEAK IDENTIFICATION CRS
CAS:<p>MONTELUKAST FOR PEAK IDENTIFICATION CRS</p>Fórmula:C35H35ClNNaO3SPeso molecular:608.1651MONTELUKAST SODIUM CRS
CAS:<p>MONTELUKAST SODIUM CRS</p>Fórmula:C35H35ClNNaO3SPeso molecular:608.1651Montelukast Sodium
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFórmula:C35H35ClNO3S·NaForma y color:White Off-White PowderPeso molecular:607.19239Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
CAS:Fórmula:C35H35ClNNaO3SPureza:98%Forma y color:SolidPeso molecular:608.1651Montelukast sodium salt
CAS:Fórmula:C35H35NO3ClNaSPureza:≥ 99.0%Forma y color:White to almost white powder or crystalsPeso molecular:608.17057Montelukast Sodium Salt
CAS:Fórmula:C35H35ClNO3S·NaForma y color:Pale Yellow SolidPeso molecular:585.18 22.99Montelukast sodium
CAS:Producto controladoFórmula:C35H35ClNO3S·NaForma y color:NeatPeso molecular:608.17Montelukast Sodium
CAS:Producto controladoFórmula:C35H35ClNO3S·NaForma y color:NeatPeso molecular:608.17Montelukast Sodium
CAS:Fórmula:C35H35ClNNaO3SPureza:>98.0%(T)(HPLC)Forma y color:White to Almost white powder to crystalPeso molecular:608.17Montelukast sodium
CAS:<p>Montelukast sodium (MK0476), an oral leukotriene antagonist for asthma, can cause rare liver injury.</p>Fórmula:C35H35ClNNaO3SPureza:99.14% - 99.89%Forma y color:White To Off-White Crystalline PowderPeso molecular:608.17Montelukast Sodium Salt
CAS:Producto controlado<p>Applications A selective leukotriene D4-receptor antagonist. Used as an antiasthmatic.<br>References Labelle, M., et al.: Bioorg. Med. Chem. Lett., 5, 283 (1995), Jones, T.R., et al.: Can. J. Physiol. Pharmacol., 73, 191 (1995), Markham, A. and Faulds, D.: Drugs, 56, 251 (1998)<br></p>Fórmula:C35H35ClNO3S·NaForma y color:White To Light YellowPeso molecular:608.17Montelukast sodium salt - Bio-X ™
CAS:<p>Montelukast is a leukotriene receptor antagonist that blocks the binding of leukotrienes to their receptors. It is used for the treatment of chronic cough, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. Montelukast binds to leukotriene receptors on cells in the airways, preventing them from attaching to leukotrienes and triggering an inflammatory response. This drug has been shown to be effective in controlling asthma symptoms by reducing bronchial hyperresponsiveness and relieving respiratory obstruction due to inflammation. Montelukast also has anti-inflammatory properties, which are thought to be due to its ability to inhibit production of pro-inflammatory cytokines such as IL-6.</p>Fórmula:C35H36ClNO3S•NaPureza:Min. 95%Forma y color:PowderPeso molecular:608.17 g/molMontelukast sodium
CAS:<p>Montelukast sodium is a leukotriene receptor antagonist that blocks the binding of leukotrienes to their receptors. It is used for the treatment of chronic cough, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. Montelukast sodium binds to leukotriene receptors on cells in the airways, preventing them from attaching to leukotrienes and triggering an inflammatory response. This drug has been shown to be effective in controlling asthma symptoms by reducing bronchial hyperresponsiveness and relieving respiratory obstruction due to inflammation. Montelukast sodium also has anti-inflammatory properties, which are thought to be due to its ability to inhibit production of pro-inflammatory cytokines such as IL-6.</p>Fórmula:C35H35ClNNaO3SPureza:Min. 95%Forma y color:PowderPeso molecular:608.17 g/molMontelukast-d6 Sodium Salt
CAS:Producto controladoFórmula:C35H29D6ClNNaO3SForma y color:NeatPeso molecular:614.2
![Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hyd…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA003S60.jpg&w=3840&q=75)
